#142: Statins benefit those at much lower CV risk; so long, Plavix; ARISTOTLE: Apixaban cuts stroke risk in all types of AF; Next-generation transcatheter aortic valve looks good; 2012 European HF guidelines

Statins benefit those at much lower CV risk; so long, Plavix; ARISTOTLE: Apixaban cuts stroke risk in all types of AF; Next-generation transcatheter aortic valve looks good; 2012 European HF guidelines

Source: Radio TheHeart.org - May 25, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts